edoc

Items where contributor is "Skoda, Radek C."

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Date | Item Type | Refereed | No Grouping
Jump to: 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008

2014

Hussein, K. and Percy, M. and McMullin, M. F. and Schwarz, J. and Schnittger, S. and Porret, N. and Martinez-Aviles, L. M. and Paricio, B. B. and Giraudier, S. and Skoda, R. and Lippert, E. and Hermouet, S. and Cario, H.. (2014) Clinical utility gene card for: Hereditary thrombocythemia. European journal of human genetics, Vol. 22, H. 2.

2013

Kubovcakova, L. and Lundberg, P. and Grisouard, J. and Hao-Shen, H. and Romanet, V. and Andraos, R. and Murakami, M. and Dirnhofer, S. and Wagner, K. U. and Radimerski, T. and Skoda, R. C.. (2013) Differential effects of hydroxyurea and INC424 on mutant allele burden and myeloproliferative phenotype in a JAK2-V617F polycythemia vera mouse model. Blood, Vol. 121, H. 7. S. 1188-1199.

Grisouard, J. and Ojeda-Uribe, M. and Looser, R. and Hao-Shen, H. and Lundberg, P. and Duek, A. and Jeandidier, E. and Karow, A. and Skoda, R. C.. (2013) Complex subclone structure that responds differentially to therapy in a patient with essential thrombocythemia and chronic myeloid leukemia. Blood, Vol. 122, H. 22. S. 3694-3696.

Girsberger, S. and Karow, A. and Lundberg, P. and Dirnhofer, S. and Lehmann, T. and Passweg, J. R. and Tichelli, A. and Skoda, R. and Rovo, A.. (2013) JAK2 V617F-mutated myeloproliferative neoplasia developing five years after wild-type JAK2 acute myeloid leukemia : a case report. Acta haematologica, Vol. 129, H. 1. S. 23-25.

2012

Lai, J. C. and Ponti, S. and Pan, D. and Kohler, H. and Skoda, R. C. and Matthias, P. and Nagamine, Y.. (2012) The DEAH-box helicase RHAU is an essential gene and critical for mouse hematopoiesis. Blood, Vol. 119, H. 18. S. 4291-4300.

de Wit, T. D. and Borkhardt, A. and Chomienne, C. and Dohner, H. and Fibbe, W. E. and Foa, R. and Hagenbeek, A. and Skoda, R. C. and Smand, C. R. and Jager, U.. (2012) Raising hematology's European voice: the importance of calling yourself a hematologist. Haematologica, Vol. 97, H. 4. S. 476-478.

2011

Chagraoui, Hedia and Kassouf, Mira and Banerjee, Sreemoti and Goardon, Nicolas and Clark, Kevin and Atzberger, Ann and Pearce, Andrew C. and Skoda, Radek C. and Ferguson, David J. P. and Watson, Steve P. and Vyas, Paresh and Porcher, Catherine. (2011) SCL-mediated regulation of the cell-cycle regulator p21 is critical for murine megakaryopoiesis. Blood, Vol. 118, H. 3. S. 723-735.

Zhang, G. and Xiang, B. and Dong, A. and Skoda, R. C. and Daugherty, A. and Smyth, S. S. and Du, X. and Li, Z.. (2011) Biphasic roles for soluble guanylyl cyclase (sGC) in platelet activation. Blood, Vol. 118, H. 13. S. 3670-3679.

Passamonti, Francesco and Elena, Chiara and Schnittger, Susanne and Skoda, Radek C. and Green, Anthony R. and Girodon, François and Kiladjian, Jean-Jacques and McMullin, Mary Frances and Ruggeri, Marco and Besses, Carles and Vannucchi, Alessandro M. and Lippert, Eric and Gisslinger, Heinz and Rumi, Elisa and Lehmann, Thomas and Ortmann, Christina A. and Pietra, Daniela and Pascutto, Cristiana and Haferlach, Torsten and Cazzola, Mario. (2011) Molecular and clinical features of the myeloproliferative neoplasm associated with JAK2 exon 12 mutations. Blood, Vol. 117, H. 10. S. 2813-2816.

Skoda, R. C. and Schwaller, J.. (2011) HiJAKing the methylosome in myeloproliferative disorders. Cancer cell, Vol. 19, H. 2. S. 161-163.

Ungureanu, Daniela and Wu, Jinhua and Pekkala, Tuija and Niranjan, Yashavanthi and Young, Clifford and Jensen, Ole N. and Xu, Chong-Feng and Neubert, Thomas A. and Skoda, Radek C. and Hubbard, Stevan R. and Silvennoinen, Olli. (2011) The pseudokinase domain of JAK2 is a dual-specificity protein kinase that negatively regulates cytokine signaling. Nature structural & molecular biology, Vol. 18, no. 9. S. 971-976.

Schaub, Franz X. and Lehmann, Thomas and Looser, Renate and Hao-Shen, Hui and Tichelli, Andre and Skoda, Radek C.. (2011) Transition to homozygosity does not appear to provide a clonal advantage to hematopoietic progenitors carrying mutations in TET2. Blood, Vol. 117, H. 6. S. 2075-2076.

2010

Bertozzi, Cara C. and Schmaier, Alec A. and Mericko, Patricia and Hess, Paul R. and Zou, Zhiying and Chen, Mei and Chen, Chiu-Yu and Xu, Bin and Lu, Min-min and Zhou, Diane and Sebzda, Eric and Santore, Matthew T. and Merianos, Demetri J. and Stadtfeld, Matthias and Flake, Alan W. and Graf, Thomas and Skoda, Radek and Maltzman, Jonathan S. and Koretzky, Gary A. and Kahn, Mark L.. (2010) Platelets regulate lymphatic vascular development through CLEC-2-SLP-76 signaling. Blood, Vol. 116, H. 4. S. 661-670.

Skoda, R. C.. (2010) JAK2 impairs stem cell function? Blood, Vol. 116, H. 9. S. 1392-1393.

Schaub, Franz X. and Looser, Renate and Li, Sai and Hao-Shen, Hui and Lehmann, Thomas and Tichelli, Andre and Skoda, Radek C.. (2010) Clonal analysis of TET2 and JAK2 mutations suggests that TET2 can be a late event in the progression of myeloproliferative neoplasms. Blood, Vol. 115, H. 10. S. 2003-2007.

Posthuma, Hidde L. A. and Skoda, Radek C. and Jacob, Frank A. and van der Maas, Anthonie P. C. and Valk, Peter J. M. and Posthuma, Eduardus F. M.. (2010) Hereditary thrombocytosis not as innocent as thought? Development into acute leukemia and myelofibrosis. Blood, Vol. 116, H. 17. S. 3375-3376.

Skoda, . (2010) Hereditary myeloproliferative disorders. Haematologica, Vol. 95, H. 1. S. 6-8.

2009

Medinger, Michael and Skoda, Radek and Gratwohl, Alois and Theocharides, Alexandre and Buser, Andreas and Heim, Dominik and Dirnhofer, Stephan and Tichelli, André and Tzankov, Alexandar. (2009) Angiogenesis and vascular endothelial growth factor-/receptor expression in myeloproliferative neoplasms: correlation with clinical parameters and JAK2-V617F mutational status. British journal of haematology, Vol. 146. S. 150-157.

Liu, Kun and Martini, Maurizio and Rocca, Bianca and Amos, Christopher I. and Teofili, Luciana and Giona, Fiorina and Ding, Jianmin and Komatsu, Hirokazu and Larocca, Luigi M. and Skoda, Radek C.. (2009) Evidence for a founder effect of the MPL-S505N mutation in eight Italian pedigrees with hereditary thrombocythemia. Haematologica : journal of hematology, Vol. 94. S. 1368-1374.

Schaub, Franz X. and Jäger, Roland and Looser, Renate and Hao-Shen, Hui and Hermouet, Sylvie and Girodon, François and Tichelli, Andre and Gisslinger, Heinz and Kralovics, Robert and Skoda, Radek C.. (2009) Clonal analysis of deletions on chromosome 20q and JAK2-V617F in MPD suggests that del20q acts independently and is not one of the predisposing mutations for JAK2-V617F. Blood : the journal of the American Society of Hematology, Vol. 113. S. 2022-2027.

Lippert, Eric and Girodon, François and Hammond, Emma and Jelinek, Jaroslav and Reading, N. Scott and Fehse, Boris and Hanlon, Katy and Hermans, Mirjam and Richard, Céline and Swierczek, Sabina and Ugo, Valérie and Carillo, Serge and Harrivel, Véronique and Marzac, Christophe and Pietra, Daniela and Sobas, Marta and Mounier, Morgane and Migeon, Marina and Ellard, Sian and Kröger, Nicolaus and Herrmann, Richard and Prchal, Josef T. and Skoda, Radek C. and Hermouet, Sylvie. (2009) Concordance of assays designed for the quantification of JAK2V617F : a multicenter study. Haematologica : journal of hematology, Vol. 94. S. 38-45.

Tiedt, Ralph and Coers, Jörn and Ziegler, Sandra and Wiestner, Adrian and Hao-Shen, Hui and Bornmann, Caroline and Schenkel, Johannes and Karakhanova, Svetlana and de Sauvage, Frederic J. and Jackson, Carl W. and Skoda, Radek C.. (2009) Pronounced thrombocytosis in transgenic mice expressing reduced levels of Mpl in platelets and terminally differentiated megakaryocytes. Blood : the journal of the American Society of Hematology, Vol. 113. S. 1768-1777.

Tefferi, Ayalew and Skoda, Radek and Vardiman, James W.. (2009) Myeloproliferative neoplasms : contemporary diagnosis using histology and genetics. Nature reviews . Clinical oncology, Vol. 6. S. 627-637.

Olcaydu, D. and Skoda, R. C. and Looser, R. and Li, S. and Cazzola, M. and Pietra, D. and Passamonti, F. and Lippert, E. and Carillo, S. and Girodon, F. and Vannucchi, A. and Reading, N. S. and Prchal, J. T. and Ay, C. and Pabinger, I. and Gisslinger, H. and Kralovics, R.. (2009) The 'GGCC' haplotype of JAK2 confers susceptibility to JAK2 exon 12 mutation-positive polycythemia vera. Leukemia, Vol. 23, no. 10. S. 1924-1926.

Goldman, J. M. and Green, A. R. and Holyoake, T. and Jamieson, C. and Mesa, R. and Mughal, T. and Pellicano, F. and Perrotti, D. and Skoda, R. and Vannucchi, A. M.. (2009) Chronic myeloproliferative diseases with and without the Ph chromosome : some unresolved issues. Leukemia, Vol. 23, no. 10. S. 1708-1715.

2008

Liu, K. and Kralovics, R. and Rudzki, Z. and Grabowska, B. and Buser, A. S. and Olcaydu, D. and Gisslinger, H. and Tiedt, R. and Frank, P. and Okoñ, K. and van der Maas, A. P. and Skoda, R. C.. (2008) A de novo splice donor mutation in the thrombopoietin gene causes hereditary thrombocythemia in a Polish family. Haematologica, Vol. 93, H. 5. S. 706-714.

Schmitt-Graeff, A. H. and Teo, S. S. and Olschewski, M. and Schaub, F. and Haxelmans, S. and Kirn, A. and Reinecke, P. and Germing, U. and Skoda, R. C.. (2008) JAK2V617F mutation status identifies subtypes of refractory anemia with ringed sideroblasts associated with marked thrombocytosis. Haematologica, Vol. 93, H. 1. S. 34-40.

Theocharides, A. and Passweg, J. R. and Medinger, M. and Looser, R. and Li, S. and Hao-Shen, H. and Buser, A. S. and Gratwohl, A. and Tichelli, A. and Skoda, R. C.. (2008) The allele burden of JAK2 mutations remains stable over several years in patients with myeloproliferative disorders. Haematologica, Vol. 93, H. 12. S. 1890-1893.

Cross, N. C. P. and Daley, G. Q. and Green, A. R. and Hughes, T. P. and Jamieson, C. and Manley, P. and Mughal, T. and Perrotti, D. and Radich, J. and Skoda, R. and Soverini, S. and Vainchenker, W. and Verstovsek, S. and Villeval, J.-L. and Goldman, J. M.. (2008) BCR-ABL1-positive CML and BCR-ABL1-negative chronic myeloproliferative disorders : some common and contrasting features. Leukemia, Vol. 22, no. 11. S. 1975-1989.

Pasqualucci, L. and Li, S. and Meloni, G. and Schnittger, S. and Gattenlohner, S. and Liso, A. and Di Ianni, M. and Martelli, M. P. and Pescarmona, E. and Foa, R. and Haferlach, T. and Skoda, R. C. and Falini, B.. (2008) NPM1-mutated acute myeloid leukaemia occurring in JAK2-V617F+ primary myelofibrosis : de-novo origin? Leukemia, Vol. 22, no. 7. S. 1459-1463.